The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Navasardyan A.R.

National Medical Research Center for Therapy and Preventive Medicine;
Bayer JSC

Lobastov K.V.

Pirogov Russian National Research Medical University

Marapov D.I.

Kazan State Medical Academy — branch of the Russian Medical Academy of Continuing Professional Education

Makarova D.D.

National Medical Research Center for Therapy and Preventive Medicine

Mikaelyan M.V.

Bayer JSC

Mareev Yu.V.

Robertson Centre for Biostatistics — University of Glasgow, U

Drapkina O.M.

National Medical Research Center for Therapy and Preventive Medicine;
A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Martsevich S.Yu.

National Medical Research Center for Therapy and Preventive Medicine

“Publication bias”, or the tendency to publish studies with positive results in medicine: aurthors’ point of view

Authors:

Navasardyan A.R., Lobastov K.V., Marapov D.I., Makarova D.D., Mikaelyan M.V., Mareev Yu.V., Drapkina O.M., Martsevich S.Yu.

More about the authors

Read: 859 times


To cite this article:

Navasardyan AR, Lobastov KV, Marapov DI, et al. . “Publication bias”, or the tendency to publish studies with positive results in medicine: aurthors’ point of view. Medical Technologies. Assessment and Choice. 2025;47(2):58‑66. (In Russ.)
https://doi.org/10.17116/medtech20254702158

References:

  1. Moss J, De Bin R. Modelling publication bias and p-hacking. Biometrics. 2023;79(1):319-331.  https://doi.org/10.1111/BIOM.13560
  2. Bespalov A, Steckler T, Skolnick P. Be positive about negatives — recommendations for the publication of negative (or null) results. European Neuropsychopharmacology. 2019;29(12):1312-1320. https://doi.org/10.1016/J.EURONEURO.2019.10.007
  3. Van Noorden R. More than 10,000 research papers were retracted in 2023 — a new record. Nature. 2023;624(7992):479-481.  https://doi.org/10.1038/D41586-023-03974-8
  4. Weber EJ. Publication bias begins at home. Emergency Medicine Journal. 2019;36(9):518-519.  https://doi.org/10.1136/EMERMED-2019-208857
  5. Mlinarić A, Horvat M, Smolčić VŠ. Dealing with the positive publication bias: Why you should really publish your negative results. Biochemia Medica (Zagreb). 2017;27(3):030201. https://doi.org/10.11613/BM.2017.030201
  6. Bruckner T, Ellis B. Clinical trial transparency: A key to better and safer medicines. Bristol, UK; 2017. Accessed February 24, 2025. https://media.wix.com/ugd/01f35d_0f2955eb88e34c02b82d886c528efeb4.pdf
  7. Therapeutic fashion and publication bias: the case of anti-arrhythmic drugs in heart attack. The James Lind Library. Accessed January 24, 2025. https://www.jameslindlibrary.org/articles/therapeutic-fashion-and-publication-bias-the-case-of-anti-arrhythmic-drugs-in-heart-attack/
  8. Dickersin K, Rennie D. Registering Clinical Trials. JAMA. 2003;290(4):516-523.  https://doi.org/10.1001/JAMA.290.4.516
  9. Hampton J. Therapeutic fashion and publication bias: the case of anti-arrhythmic drugs in heart attack. Journal of the Royal Society of Medicine. 2015;108(10):418-420.  https://doi.org/10.1177/0141076815608562
  10. Hine LK, Laird N, Hewitt P, Chalmers TC. Meta-analytic Evidence Against Prophylactic Use of Lidocaine in Acute Myocardial Infarction. Archives of Internal Medicine. 1989;149(12):2694-2698. https://doi.org/10.1001/ARCHINTE.1989.00390120056011
  11. Cowley AJ, Skene A, Stainer K, Hampton JR. The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: an example of publication bias. International Journal of Cardiology. 1993;40(2):161-166.  https://doi.org/10.1016/0167-5273(93)90279-P
  12. Cohen D. Rosiglitazone: what went wrong? BMJ. 2010;341:c4848.. https://doi.org/10.1136/BMJ.C4848
  13. Nissen SE, Wolski K. Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes. New England Journal of Medicine. 2007;356(24):2457-2471. https://doi.org/10.1056/NEJMoa072761
  14. USDOJ: US Attorney’s Office — District of Massachusetts. GlaxoSmithKline Pleads Guilty and is Sentenced to Pay One Billion Dollars in Criminal Fine and Forfeiture. Accessed January 24, 2025. https://www.justice.gov/archive/usao/ma/news/2012/July/GSKsentencing.html
  15. Greener M. First do no harm. Improving drug safety through legislation and independent research. EMBO Reports. 2008;9(3):221-224.  https://doi.org/10.1038/EMBOR.2008.17
  16. USDOJ: US Attorney’s Office — District of Massachusetts. Merck Sharp & Dohme Pleads Guilty to Misbranding Vioxx®. Accessed January 24, 2025. https://www.justice.gov/archive/usao/ma/news/2011/December/MerckPleaPR.html
  17. Wadman M. Merck settles Vioxx lawsuits for $4.85 billion. Nature. Published online November 13, 2007. https://doi.org/10.1038/450324B
  18. Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet. 2009;373(9665):746-758.  https://doi.org/10.1016/S0140-6736(09)60046-5
  19. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet. 2004;363(9418):1341-1345. https://doi.org/10.1016/S0140-6736(04)16043-1
  20. Le Noury J, Nardo JM, Healy D, Jureidini J, Raven M, Tufanaru C, et al. Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. BMJ. 2015;351:h4320. https://doi.org/10.1136/BMJ.H4320
  21. USDOJ: US Attorney’s Office — District of Massachusetts. GlaxoSmithKline Pleads Guilty and is Sentenced to Pay One Billion Dollars in Criminal Fine and Forfeiture. Accessed January 24, 2025. https://www.justice.gov/archive/usao/ma/news/2012/July/GSKsentencing.html
  22. Jack A. Tamiflu: “a nice little earner.” BMJ. 2014;348:g2524. https://doi.org/10.1136/BMJ.G2524
  23. Jefferson T, Jones M, Doshi P, Del Mar C. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ. 2009;339:b5106.
  24. Saposnik G, Redelmeier D, Ruff CC, Tobler PN. Cognitive biases associated with medical decisions: a systematic review. Medical Informatics and Decision Making. 2016;16(1):138.  https://doi.org/10.1186/S12911-016-0377-1
  25. Thirsk LM, Panchuk JT, Stahlke S, Hagtvedt R. Cognitive and implicit biases in nurses’ judgment and decision-making: A scoping review. International Journal of Nursing Studies. 2022;133:104284. https://doi.org/10.1016/J.IJNURSTU.2022.104284
  26. Tversky A, Kahneman D. Judgment under Uncertainty: Heuristics and Biases. Science. 1974;185(4157):1124-1131. https://doi.org/10.1126/SCIENCE.185.4157.1124
  27. Addimando F. Fundamentals of Neuroscience. In: Negotiation Neuroscience. Springer, Cham; 2024:29-60.  https://doi.org/10.1007/978-3-031-69754-8_2
  28. Das TK, Teng BS. Cognitive biases and strategic decision processes: An integratwe perspective. Journal of Management Studies. 1999;36(6):757-778.  https://doi.org/10.1111/1467-6486.00157
  29. Loncharich MF, Robbins RC, Durning SJ, Soh M, Merkebu J. Cognitive biases in internal medicine: a scoping review. Diagnosis (Berlin). 2023;10(3):205-214.  https://doi.org/10.1515/DX-2022-0120
  30. Elston DM. Confirmation bias in medical decision-making. Journal of the American Academy of Dermatology. 2020;82(3):572.  https://doi.org/10.1016/J.JAAD.2019.06.1286
  31. Bystranowski P, Janik B, Próchnicki M, Skórska P. Anchoring effect in legal decision-making: A meta-analysis. Law and Human Behavior. 2021;45(1):1-23.  https://doi.org/10.1037/LHB0000438
  32. Roese NJ, Vohs KD. Hindsight Bias. Perspectives on Psychological Science. 2012;7(5):411-426.  https://doi.org/10.1177/1745691612454303
  33. Huang C, Li Y, Jiang L. Dual effects of conformity on the evolution of cooperation in social dilemmas. Physical Review E. 2023;108(2-1):024123. https://doi.org/10.1103/PHYSREVE.108.024123
  34. Fasolo B, Heard C, Scopelliti I. Mitigating Cognitive Bias to Improve Organizational Decisions: An Integrative Review, Framework, and Research Agenda. Journal of Management. 2024:10.1177/01492063241287188. https://doi.org/10.1177/01492063241287188
  35. Duyx B, Urlings MJE, Swaen GMH, Bouter LM, Zeegers MP. Scientific citations favor positive results: a systematic review and meta-analysis. Journal of Clinical Epidemiology. 2017;88:92-101.  https://doi.org/10.1016/J.JCLINEPI.2017.06.002
  36. Lin L, Chu H. Quantifying publication bias in meta-analysis. Biometrics. 2018;74(3):785-794.  https://doi.org/10.1111/BIOM.12817
  37. Martsevich SYu, Navasardyan AR, Lobastov KV, Mikaelyan MV, Mixajlenko EV, Suvorov AYu, et al. Systematic review and meta-analysis: a critical examination of the methodology. Racional`naya farmakoterapiya v kardiologii. 2023;19(4):382-397. (In Russ.). https://doi.org/10.20996/1819-6446-2023-2923
  38. Persson PB. Good publication practice in physiology 2017: Current Revisions of the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals. Acta Physiologica (Oxford). 2017;221(4):283-284.  https://doi.org/10.1111/apha.12984
  39. WHO Statement on Public Disclosure of Clinical Trial Results Background. Accessed January 24, 2025. https://www.who.int/news/item/09-04-2015-japan-primary-registries-network
  40. International Standards for Clinical Trial Registries. Published online 2018. Accessed January 24, 2025. https://iris.who.int/bitstream/handle/10665/274994/9789241514743-eng.pdf
  41. Food and Drug Administration Amendments Act (FDAAA) of 2007. FDA. Accessed January 24, 2025. https://www.fda.gov/regulatory-information/selected-amendments-fdc-act/food-and-drug-administration-amendments-act-fdaaa-2007
  42. Commission Guideline — Guidance on posting and publication of result-related information on clinical trials in relation to the implementation of Article 57(2) of Regulation (EC) No 726/2004 and Article 41(2) of Regulation (EC) No 1901/2006. Accessed January 24, 2025. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52012XC1006(01)
  43. Goldacre B, Devito NJ, Heneghan C, Irving F, Bacon S, Fleminger J, et al. Compliance with requirement to report results on the EU Clinical Trials Register: cohort study and web resource. BMJ. 2018;362:k3218. https://doi.org/10.1136/bmj.k3218

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.